The United States spends more on healthcare per capita than any other country in the world. For example, a medical procedure ...

Meanwhile, cultural attitudes around concepts like “rugged individualism” and “freedom of choice” have long been deployed to ...

Despite the popularity of generic and biosimilar drugs in Europe—the latter of which have struggled to catch on in the ...

Generative AI chatbot for doctors called 'Prof. Valmed' earns E.U. approval. In the U.S., FDA is yet to issue guidelines on ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

European policy makers and healthcare providers must continue to encourage data sharing and standardisation, and resist retreating into self-made or ad hoc approaches to delivering precision medicine.

UK is first European country to approve Eisai and Biogen's Alzheimer's drug Leqembi, after EU advisors say safety concerns outweigh its benefits.